Skip to content
10-Q

Quarterly Report

GB SCIENCES INC

0001437749-23-032645

← back to feed
Filed
Nov 20, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Nov 20, 2023 402.74M sh
Cash And Equivalents Q2 2024 · Sep 30, 2023 $104.53K
Cash And Equivalents Q2 2024 · Dec 31, 2022 $109.91K
Stockholders Equity Q2 2024 · Sep 30, 2023 −$4.69M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$4.41M
Current Liabilities Q2 2024 · Sep 30, 2023 $4.85M
Current Liabilities Q2 2024 · Dec 31, 2022 $4.76M
Total Liabilities Q2 2024 · Sep 30, 2023 $4.93M
Total Liabilities Q2 2024 · Dec 31, 2022 $4.76M
Current Assets Q2 2024 · Sep 30, 2023 $234.19K
Current Assets Q2 2024 · Dec 31, 2022 $309.5K
Total Assets Q2 2024 · Sep 30, 2023 $234.19K
Total Assets Q2 2024 · Dec 31, 2022 $352.32K
Operating Cash Flow Q2 2024 · Sep 30, 2022 −$907.56K
Eps Basic Q2 2024 · Sep 30, 2022 $0.00
Eps Basic Q2 2024 · Sep 30, 2022 $0.00
Sga Expense Q2 2024 · Sep 30, 2022 $275.84K
Sga Expense Q2 2024 · Sep 30, 2022 $735.36K
Net Income Q2 2024 · Sep 30, 2022 −$313.06K
Net Income Q2 2024 · Sep 30, 2022 −$811.15K
Operating Income Q2 2024 · Sep 30, 2022 −$275.84K
Operating Income Q2 2024 · Sep 30, 2022 −$735.36K
Gross Profit Q2 2024 · Sep 30, 2022 $0
Gross Profit Q2 2024 · Sep 30, 2022 $0
Cost Of Revenue Q2 2024 · Sep 30, 2022 $0
Cost Of Revenue Q2 2024 · Sep 30, 2022 $0
Revenue Q2 2024 · Sep 30, 2022 $0
Revenue Q2 2024 · Sep 30, 2022 $0